GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Total Assets

Biosino Bio-Technology and Science (HKSE:08247) Total Assets : HK$577.4 Mil (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Total Assets?

Biosino Bio-Technology and Science's Total Assets for the quarter that ended in Jun. 2024 was HK$577.4 Mil.

During the past 3 years, the average Total Assets Growth Rate was -7.30% per year. During the past 5 years, the average Total Assets Growth Rate was -6.90% per year. During the past 10 years, the average Total Assets Growth Rate was 5.50% per year.

During the past 13 years, Biosino Bio-Technology and Science's highest 3-Year average Total Assets Growth Rate was 27.90%. The lowest was -7.30%. And the median was 11.10%.

Total Assets is connected with ROA %. Biosino Bio-Technology and Science's annualized ROA % for the quarter that ended in Jun. 2024 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Biosino Bio-Technology and Science's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.


Biosino Bio-Technology and Science Total Assets Historical Data

The historical data trend for Biosino Bio-Technology and Science's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Total Assets Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 717.68 740.44 744.18 673.65 616.07

Biosino Bio-Technology and Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 631.54 - 616.07 577.39

Biosino Bio-Technology and Science Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Biosino Bio-Technology and Science's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=253.105+362.967
=616.1

Biosino Bio-Technology and Science's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (Q: Jun. 2024 )+Total Liabilities (Q: Jun. 2024 )
=229.376+348.016
=577.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosino Bio-Technology and Science  (HKSE:08247) Total Assets Explanation

Total Assets is connected with ROA %.

Biosino Bio-Technology and Science's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0/( (616.072+577.392)/ 2 )
=0/596.732
=0.00 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Biosino Bio-Technology and Science's Asset Turnover for the quarter that ended in Jun. 2024 is

Asset Turnover
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0/( (616.072+577.392)/ 2 )
=0/596.732
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Biosino Bio-Technology and Science Total Assets Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosino Bio-Technology and Science Business Description

Traded in Other Exchanges
N/A
Address
No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. The Company has one reportable operating segment, the in-vitro diagnostic reagent products segment, which manufactures, sells and distributes a variety of mono/double diagnostic reagent products. The company's revenue is generated from customers located in Mainland China.
Executives
Beijing Enterprises Group Company Limited 2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited 2101 Beneficial owner
Hk Zhixin Investment Co., Ltd. 2101 Beneficial owner
Li Dongfeng 2201 Interest of corporation controlled by you
Yan Kang 2201 Interest of corporation controlled by you
Qiu Zhe Feng 2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Yang Yi Xiong 2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science Headlines

No Headlines